Search Results

Eli Lilly’s new research and development facility in Boston’s Seaport district will focus on DNA- and RNA-based therapies, as well as other priority areas such as diabetes and obesity.

Novo Holdings, a leading life science investor, announced that its Boston office has been named a 2024 Best Place to Work by the Boston Business Journal.

Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Silk Road Medical, Inc.

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2024, on Wednesday, July 24, 2024, at 8:00 a.m. ET.

Boston Pharmaceuticals today announced the appointment of Margaret Koziel, M.D., as Chief Medical Officer (CMO). Juan Carlos Lopez-Talavera, M.D., Ph.D., who has served as acting CMO since December 2023, will move to an advisory role to Dr. Koziel and the Boston Pharmaceuticals team as the company advances its promising late-stage candidate BOS-580.

Looking for a biopharma job in the Boston area? Check out these top five companies hiring life sciences professionals like you.

Silk Road Medical, Inc. announced it has entered into a definitive agreement to be acquired by Boston Scientific Corporation, a global medical technology leader, for $27.50 in cash per share, representing an equity value of approximately $1.26 billion.

Aptevo Therapeutics Inc. today announced a presentation at The Essential Protein & Antibody Engineering Summit (PEGS) conference in Boston MA.

Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences in May.

Cue Biopharma, Inc. announced today that it will deliver two poster presentations at the 20th PEGS Boston Summit, the Essential Protein and Antibody Engineering Summit, being held May 13-17, 2024 in Boston, MA and virtually.